Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease | Zendy

Yvonne Huber | Zendy; Christian Labenz | Zendy; Maurice Stephan Michel | Zendy; MarcusA Wörns | Zendy; Peter R. Galle | Zendy; Karel Kostev | Zendy; Jörn M. Schattenberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tumor Incidence in Patients with Non-Alcoholic Fatty Liver Disease

Author(s) -

Yvonne Huber,

Christian Labenz,

Maurice Stephan Michel,

MarcusA Wörns,

Peter R. Galle,

Karel Kostev,

Jörn M. Schattenberg

Publication year - 2020

Publication title -

deutsches ärzteblatt international

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.436

H-Index - 60

ISSN - 1866-0452

DOI - 10.3238/arztebl.2020.0719

Subject(s) - medicine , fatty liver , incidence (geometry) , hepatocellular carcinoma , breast cancer , cancer , gastroenterology , liver cancer , confidence interval , comorbidity , disease , oncology , physics , optics

The incidence of cancer is increasing worldwide. The role of comorbidities in this development is debated. The aim of this study was to investigate the significance of non-alcoholic fatty liver disease (NAFLD) for the incidence of cancer of various kinds in Germany.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research